Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

insingulosolutions.com

Founded Year

2017

Stage

Seed VC | Alive

Total Raised

$410K

Last Raised

$410K | 3 yrs ago

About In Singulo Solutions

In Singulo Solutions is a Sweden based technology company that develops label free methods that allow to overcome the challenges of label free biosensing in drug development and research. In Singulo Solutions’ single molecule surface-sensitive microscopy-based method contributes to this challenge probing the interaction between potential drug compounds and membrane proteins with single molecule resolution. It is enabling inhibition in solution perturbations of the interaction to reveal detailed kinetic information, coined dynamic inhibition in solution assay, or dISA in short.

In Singulo Solutions Headquarters Location

Bioventure Hub Pepparedsleden 1

Molndal, 431 83,

Sweden

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing In Singulo Solutions

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

In Singulo Solutions is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

In Singulo Solutions Patents

In Singulo Solutions has filed 1 patent.

The 3 most popular patent topics include:

  • Biotechnology
  • Chemokine receptors
  • Clusters of differentiation
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/2/2019

5/31/2022

Cytokines, Clusters of differentiation, Molecular biology, Chemokine receptors, Biotechnology

Grant

Application Date

8/2/2019

Grant Date

5/31/2022

Title

Related Topics

Cytokines, Clusters of differentiation, Molecular biology, Chemokine receptors, Biotechnology

Status

Grant

  • When was In Singulo Solutions founded?

    In Singulo Solutions was founded in 2017.

  • Where is In Singulo Solutions's headquarters?

    In Singulo Solutions's headquarters is located at Bioventure Hub, Molndal.

  • What is In Singulo Solutions's latest funding round?

    In Singulo Solutions's latest funding round is Seed VC.

  • How much did In Singulo Solutions raise?

    In Singulo Solutions raised a total of $410K.

  • Who are the investors of In Singulo Solutions?

    Investors of In Singulo Solutions include Chalmers Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.